Use of fall risk-increasing drugs in older adults with multiple myeloma: A cross-sectional study

Journal of Geriatric Oncology - Tập 13 - Trang 493-498 - 2022
Taisa Roberta Lopes Machado1, Cristiane Aparecida Menezes de Pádua1, Paula Lana de Miranda Drummond1,2, Lívia Pena Silveira1,3, Jéssica Soares Malta1, Roberta Márcia Marques dos Santos2, Naiane Lima Costa1, Adriano Max Moreira Reis1
1Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
2Fundação Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil
3Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Tài liệu tham khảo

Dempsey, 2019, The pharmacologic management of multiple myeloma in older adults, Expert Opin Pharmacother, 20, 887, 10.1080/14656566.2019.1577822 João, 2020, Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: deliberations and recommendations from an expert panel of hematologists, J Geriatr Oncol, 11, 1210, 10.1016/j.jgo.2020.06.002 Palumbo, 2015, Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report, Blood, 125, 2068, 10.1182/blood-2014-12-615187 Kaweme, 2021, Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects, Front Med (Lausanne), 25 Schoenbeck, 2021, Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma, J Geriatr Oncol, 10.1016/j.jgo.2021.02.009 Wildes, 2018, Falls in older adults with multiple myeloma, Eur J Haematol [SL], 100, 273, 10.1111/ejh.13009 Wildes, 2021, 10, 3563 Covington, 2020, Understanding fall risk for older adults with cancer: an evaluation of experts perceptions, J Geriatr Oncol, 2, 263, 10.1016/j.jgo.2019.06.006 Hart, 2020, Use of fall risk–increasing drugs around a fall-related injury in older adults: a systematic review, J Am Geriatr Soc, s.l., 2645 Seppala, 2020, 249 Ward, 2014, Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study, J Geriatr Oncol, 5, 57, 10.1016/j.jgo.2013.10.002 Morris, 2020, Falls and cancer, Clin Oncol, 10.1016/j.clon.2020.03.011 Umıt, 2019, Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, J Oncol Pharm Pract Sattar, 2021, Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment, Support Care Cancer, 1, 21, 10.1007/s00520-020-05619-2 United Nations, Department of Economic and Social Affairs, Population Division, 2015 Beasley, 2009, Development and implementation of a pharmacy fall prevention program, Hosp Pharm, 44, 1095, 10.1310/hpj4412-1095 Yazdani, 2017, Evaluation of the “medication fall risk score”, Am J Health Syst Pharm, 74, 10.2146/ajhp150745 Agency for Healthcare Research and Quality (AHRQ), 2013 Vilholm, 2014, Drug-induced peripheral neuropathy, Basic Clin Pharmacol Toxicol [SL], 115, 185, 10.1111/bcpt.12261 Jones, 2019, Drug-induced peripheral neuropathy: a narrative review, Curr Clin Pharmacol [SL], 15, 38 Gnjidic, 2012, Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes, J Clin Epidemiol, 65, 989, 10.1016/j.jclinepi.2012.02.018 Reis, 2017, Factors associated with the use of potentially inappropriate medications by older adults with cancer, J Geriatr Oncol, 8, 303, 10.1016/j.jgo.2017.05.003 American Geriatrics Society, 2019, Updated AGS beers criteria® for potentially inappropriate medication use in older adults, J Am Geriatr Soc [SL], 67, 674, 10.1111/jgs.15767 Elias, 2019, The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events, Drugs, 79, 715, 10.1007/s40265-019-01110-3 Lewis, 2014, Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study, J Bone Miner Res, 11, 2489, 10.1002/jbmr.2279 Poly, 2019, Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies, Osteoporos Int, 1, 103, 10.1007/s00198-018-4788-y Carrière, 2016, Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort, Osteoporos Int, 11, 3187, 10.1007/s00198-016-3667-7 Gebara, 2015, Cause or effect? Selective serotonin reuptake inhibitors and falls in older adults: a systematic review, Am J Geriatr Psychiatry, 23, 1016, 10.1016/j.jagp.2014.11.004 De Vries, 2018, Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs, J Am Med Dir Assoc, 19, 371.e1, 10.1016/j.jamda.2017.12.013 Dharmarajan, 2015, Tolerability of antihypertensive medications in older adults, Drug Aging [sl], 32, 773, 10.1007/s40266-015-0296-3 Molassiotis, 2019, Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy, Brain Behav, 9, 10.1002/brb3.1312 Sánchez-Barroso, 2019, Concomitant medications and risk of chemotherapy-induced peripheral neuropathy, Oncologist, 24, e784, 10.1634/theoncologist.2018-0418 Stein, 2021, Association between neuropathy and B-vitamins: a systematic review and meta⠰analysis, Eur J Neurol [SL], 28, 2054, 10.1111/ene.14786 Diamond, 2017, Managing multiple myeloma in elderly patients, Leukemia Lymphoma [SL], 59, 1300, 10.1080/10428194.2017.1365859 Zweegman, 2017, Elderly patients with multiple myeloma, Curr Opin Oncol, 29, 315, 10.1097/CCO.0000000000000395 Nightingale, 2017, Polypharmacy in older adults with cancer: evaluating polypharmacy as part of the geriatric assessment, Curr Geriatr Rep, 6, 219, 10.1007/s13670-017-0221-1 Nightingale, 2015, Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer, J Clin Oncol, 33, 1453, 10.1200/JCO.2014.58.7550 Kierner, 2015, Polypharmacy in the terminal stage of cancer, Support Care Cancer, 24, 2067, 10.1007/s00520-015-3007-z Sharma, 2016, Polypharmacy and potentially inappropriate medication use in geriatric oncology, J Geriatr Oncol, 7, 346, 10.1016/j.jgo.2016.07.010 Turner, 2016, Polypharmacy cut-points in older people with cancer: how many medications are too many?, Support Care Cancer, 24, 1831, 10.1007/s00520-015-2970-8 Richardson, 2015, Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults, Age Ageing, 44, 90, 10.1093/ageing/afu141